KRAS and cancer: In the basal cancer cells, which are a dominant cancer epithelial cell type in these tumors (Supplemental Fig. 2a), enrichment of EMT was concurrent with increased immune response, K-Ras signaling, cellular stress responses, and angiogenesis, and decreased oxidative phosphorylation, myc targets, and E2F targets with age (Fig. 3a–e).